News and blogs
166 results found.
First study on vaccine effectiveness in people with cancer
Read Blood Cancer UK's response to the first study on Covid vaccine effectiveness in people with cancer.
Should people with blood cancer get an antibody test?
Read more about what people with blood cancer should know about antibody tests and the Covid vaccine.
Professor Jim Allan's research on CLL (chronic lymphocytic leukaemia)
Watch Blood Cancer UK's video which takes a look at Professor Jim Allan's research into treatments for CLL.
Antibiotic could help treat MLL-AML
Discover how research by Cancer Research UK and Blood Cancer UK found an antibiotic could treat a type acute myeloid leukaemia (AML).
How dangerous is Covid-19 for people with blood cancer?
Read Blood Cancer UK's article looking at study's on how dangerous Covid-19 is for people with different types of blood cancer.
How was the coronavirus vaccine created?
Learn how the coronavirus vaccines were made, including information on clinical trials, vaccine approvals and long-term side effects.
The coronavirus vaccine: what you need to know
We outline what we know about the potential coronavirus vaccines, and explore what they could mean for people with blood cancer.
How does the coronavirus affect people with blood cancer?
Blood Cancer UK are funding vital research that will explore how different types of blood cancer might affect someone’s individual level of risk from coronavirus.
Our aim to beat blood cancer in a generation
Learn how Blood Cancer UK aim to beat blood cancer in a generation.
Does having blood cancer put you at greater risk from the coronavirus?
Find out if people with blood cancers are more likely to suffer severe and life-threatening COVID-19 than healthy individuals.
How could a coronavirus vaccine help people with blood cancer?
Find out how coronavirus vaccines work and their potential to protect people with blood cancer.
EHA annual conference 2020: the promising future of blood cancer research
Blood Cancer UK rounds up the exciting breakthroughs in blood cancer research discussed at this year’s European Haematology Association conference.
What effect is COVID-19 having on blood cancer research?
Find out how blood cancer research is being effected by the COVID-19 pandemic.
New research hope for those with a rare type of leukaemia
Blood Cancer UK research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
Why are people with blood cancer being told to shield for 12 weeks?
Here's the information we have on why people with blood cancer are being asked to shield.
Could a blood cancer drug be used to help people with COVID-19?
Calquence is being trialled in patients with COVID-19 who are critically ill, in the hope that it may reduce damage to their lungs.
Could a blood cancer drug be used to help people with COVID-19?
Calquence is being trialled in patients with COVID-19 who are critically ill, in the hope that it may reduce damage to their lungs.
Leukaemia protective role of Y chromosome gene discovered
Scientists funded by Blood Cancer UK have discovered the first leukaemia protective gene that is specific to the male-only Y chromosome.
Leukaemia - how we can use information to treat it
Why finding about how we get leukaemia in the first place is so important for developing new treatments.
How does the immune system destroy Hodgkin lymphoma?
In Hodgkin lymphoma, the cells which are the root cause of the cancer are hidden within a much larger number of white blood cells.